Stockholders' Deficiency (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Common Stock to investors, shares		116,670
Common Stock to investors, net proceeds		$ 525,004
Proceeds related to private placement offering, value	3,501,975
Proceeds related to private placement offering, units	3,501,975
Proceeds related to private placement offering, per unit	$ 1.00
Amount received from officer		500,000
Amount classified as restricted cash		850,002
Granted options to purchase Common Stock		416,000
Aggregate intrinsic value of exercised	0	932,795
Weighted average annual rate of option grants	4.00%	5.00%
Weighted average fair value of the stock granted	$ 0.91	$ 5.39
Stock-based compensation expense related to stock options/ warrants	558,286	556,148
Stock-based compensation expense related to stock options/ warrants, unamortized	1,693,482
Stock-based compensation expense related to stock options/ warrants, amortized	801,913
Weighted average remaining period	1 year 8 months 12 days
Common Stock to three holders of warrants		1,465,578
Common Stock to three holders of warrants, exercised		2,353,744
Common Stock to several holders of warrants	10,342,931
Common Stock to several holders of warrants, exercised	12,505,023
Stock-based compensation expense related for consultant warrants	(17,718)
Imputed the value of the services contributed	350,000
Recorded salary expense	350,000
Warrant [Member]
Aggregate intrinsic value of exercised	16,983,736	10,316,439
Weighted average fair value of the stock granted	$ 1.34	$ 3.83
Stock-based compensation expense related to stock options/ warrants	490,420	4,794
Stock-based compensation expense related to stock options/ warrants, unamortized	583,481
Stock-based compensation expense related to stock options/ warrants, amortized	1,864
Weighted average remaining period	6 months
Series B Preferred Stock [Member]
Share issued upon conversion	8.22	5.00
Beneficial Conversion Feature Related to Incremental Shares	1,359,854
Beneficial Conversion Feature Related to Incremental Value	1,532,722
Accrued contractual dividends	279,380	261,084
Series A Preferred Stock [Member]
Series A Preferred Stock are available to be issued	44,443
Series C Preferred Stock [Member]
Deemed dividends		$ 433,606